Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Gross To Net Adjustments Reserve by Product
Chargebacks, Discounts for Prompt Pay and Other Allowances$20.83M+136%$8.84M+45.8%$6.06M+41.6%$4.28M-4.8%$4.5M+7.3%
Rebates, Co-Pay Assistance, Returns, and Other$122.73M+35.6%$90.5M
Provision related to sales in the current year by Product
Chargebacks, Discounts for Prompt Pay and Other Allowances$37.82M+144%$15.53M+52.6%$10.18M+78.8%$5.69M+8.7%$5.24M+160%
Rebates, Co-Pay Assistance, Returns, and Other$128.95M
Gross To Net Adjustments Reserve Credits And Payments Made by Product
Chargebacks, Discounts for Prompt Pay and Other Allowances$23.85M+90.8%$12.5M+52.2%$8.22M+40.8%$5.83M+50.9%$3.87M+301%
Rebates, Co-Pay Assistance, Returns, and Other$94.36M
Adjustments related to prior year sales by Product
Chargebacks, Discounts for Prompt Pay and Other Allowances-$1.98M-682%-$253K-39.8%-$181K-148%-$73K+93.2%-$1.07M
Rebates, Co-Pay Assistance, Returns, and Other-$2.37M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Madrigal Pharmaceuticals, Inc. break its business down?
Madrigal Pharmaceuticals, Inc. (MDGL) reports gross to net adjustments reserve by product across 2 parts — Chargebacks, Discounts for Prompt Pay and Other Allowances and Rebates, Co-Pay Assistance, Returns, and Other. Each is extracted from the segment footnotes and tracked over time.
Where does Madrigal Pharmaceuticals, Inc.'s segment data come from?
Segment breakdowns are pulled from the segment footnotes in Madrigal Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.